Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2022 Financial Results

MISSISSAUGA, ON, May 26, 2022 /PRNewswire/ – Covalon Technologies Ltd. (the “Enterprise” or “Covalon”) (TSXV: COV) (OTC: CVALF), an innovative medical technologies enterprise, will launch its Q2 Fiscal 2022 fiscal outcomes on Monday May possibly 30^th, 2022, ahead of marketplaces open. A meeting simply call and webcast to discuss the financial outcomes will be held on Monday May perhaps 30^th, 2022, at 9:00am EST.

To perspective, hear to, and participate in the are living webcast, remember to stick to the connection underneath:

https://produceredition.webcasts.com/starthere.jsp?ei=1551026&tp_vital=74c818f1fa

To listen and take part by means of the meeting get in touch with, please dial:

North American Toll-No cost: 1-888-664-6392

Area (Toronto): 416-764-8659

Affirmation Number: 10020730

Contributors will be in a position to talk to concerns of Company administration all through the Q&A part of the conference phone possibly by asking them on the connect with or by publishing them working with the chat perform on the webcast.

A recording of the contact will be available by contacting 1-888-390-0541 or 416-764-8677 and getting into the encore replay entry code 020730# until June 13^th, 2022. A recording of the phone will also be out there on www.covalon.com below Information & Activities on the Investors tab.

Copies of Covalon’s fiscal statements and MD&A can be attained on SEDAR at www.sedar.com and beneath Sedar Filings on the Buyers tab of Covalon’s site.

About Covalon

Covalon Systems Ltd. is a researcher, developer, maker, and marketer of patent-protected healthcare products and solutions that increase affected individual outcomes and preserve life in the locations of superior wound treatment, infection management and surgical procedures. Covalon leverages its patented health care technology platforms and knowledge in two techniques: (i) by developing merchandise that are bought beneath Covalon’s identify and (ii) by building and commercializing clinical products and solutions for other health-related companies under growth and license contracts. The Enterprise is listed on the TSX Venture Trade, getting the image COV and trades on the OTQX Market beneath the symbol CVALF. To discover a lot more about Covalon, take a look at our internet site at www.covalon.com.

Neither TSX Undertaking Trade nor its Regulation Providers Supplier (as that phrase is defined in the insurance policies of the TSX Undertaking Exchange) accepts responsibility for the adequacy or precision of this launch.

This news launch incorporates forward-searching statements which replicate the Firm’s latest expectations with regards to long term situations. The forward-searching statements are frequently, but not constantly, recognized by the use of terms this kind of as “search for”, “foresee”, “approach, “estimate”, “anticipate”, “intend” and statements that an occasion or result “could”, “will”, “should really”, “could” or “could” manifest or be realized and other comparable expressions. These forward-searching statements include threat and uncertainties, which include the problems in predicting solution approvals, acceptance of and calls for for new merchandise, the impression of the solutions and pricing procedures of opponents, delays in acquiring and launching new products and solutions, the regulatory ecosystem, fluctuations in functioning final results, the impact and timing of COVID-19 on functioning pursuits and sector problems, and other challenges, any of which could result in success, functionality, or achievements to differ materially from the benefits talked about or implied in the forward-seeking statements. Numerous threats are inherent in the sector others are more distinct to the Corporation. Investors need to seek advice from the Firm’s ongoing quarterly filings for added details on pitfalls and uncertainties relating to these ahead-on the lookout statements. Investors really should not position undue reliance on any ahead-seeking statements. The Corporation assumes no obligation to update or alter any ahead-hunting statements irrespective of whether as a final result of new information, further functions or usually.

View original content material to download multimedia:https://www.prnewswire.com/news-releases/covalon-announces-conference-phone-to-talk about-second-quarter-fiscal-2022-economical-effects-301555723.html